Delivery Order SPE2DB24D8002-SPE2DB25FJMSN
Award Date
11/15/24
Potential Completion Date
11/18/24
Potential Value
$21K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $5,560.45 firm-fixed-price delivery order is for the supply of Eliquis 5 mg tablets. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $1,221.90 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a prescription anticoagulant medication. The award is associated with a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. under the DLA Troop Support...
This federal contract, awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., is a $2,864.79 firm fixed-price delivery order for the supply of Eliquis 5 mg tablets. The award, which does not have a set-aside designation, is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc., a self-certified small disadvantaged business, to provide a range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S....
This federal contract award, valued at $5,011.95, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Eliquis 5 mg tablets to support U.S. Armed Forces medical operations. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V Program. This IDC allows the company...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The contract has a ceiling value of $13,109.49 and a period of performance through August 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical's ECAT Generation V Program, which has a total potential value of $999,999,999.00 and is used to procure...
This federal contract award, ID SPE2DB24D8001|SPE2DB25FKYVY, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of 4,566,491,125 units of the medication Eliquis 5 mg Tablet 60s. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,648.27 and a period of performance through November 20, 2024. Dakota Drug, Inc. is the prime contractor, and this award is not associated with a set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 5 mg tablets. The award, with a ceiling value of $4,188.11, is a firm fixed-price delivery order contract with a completion date of February 9, 2024. Dakota Drug, Inc. is a key strategic supplier for the DLA's medical supply chain needs, holding a significant single-award Indefinite Delivery...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,138.04 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets, a prescription medication. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, under the agency's ECAT Generation V Program. This single-award IDC allows the company to provide a...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The $11,102.42 firm fixed-price delivery order contract is for the supply of ELIQUIS 5 MG TABLET 60S, a pharmaceutical product, with a performance period ending on July 6, 2022. The contract is not set-aside and is part of Dakota Drug's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Eliquis 2.5 mg tablets. The contract, valued at $4,453.50, has a period of performance through November 20, 2024. This award is under DLA's ECAT Generation V Program, a large indefinite delivery contract (IDC) valued at $999,999,999.00 that enables Dakota Drug, Inc. to provide a wide range of pharmaceutical products,...